The immune microenvironment in cutaneous leishmaniasis

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 6, 2015, Pages 1170-1179

  Jabbour, M N ^a   Issa, G ^a   Charafeddine, K ^a   Simaan, Y ^b   Karam, M ^b   Khalifeh, H ^a   Habib, R ^a   Khalifeh, I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; SYNDECAN 1; T6 ANTIGEN; CD1 ANTIGEN; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AMASTIGOTE; ANTIGEN EXPRESSION; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LANGERHANS CELL; LEISHMANIA MAJOR; LEISHMANIA TROPICA; MACROPHAGE; MALE; PRIORITY JOURNAL; PUNCH BIOPSY; SKIN BIOPSY; SKIN DEFECT; SKIN LEISHMANIASIS; DERMIS; EPIDERMIS; IMMUNOLOGY; PATHOLOGY; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; YOUNG ADULT;

ADOLESCENT; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELLULAR MICROENVIRONMENT; CHILD; DERMIS; EPIDERMIS; FEMALE; HUMANS; LANGERHANS CELLS; LEISHMANIA MAJOR; LEISHMANIA TROPICA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MALE; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84929645739     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12781     Document Type: Article

References (65)

1. Grevelink SA, Lerner EA,. Leishmaniasis. J Am Acad Dermatol 1996 Feb; 34 (2 Pt 1): 257-272.
2. Douba M, Mowakeh A, Wali A,. Current status of cutaneous leishmaniasis in Aleppo, Syrian Arab Republic. Bull World Health Organ 1997; 75: 253-259. PubMed PMID: 9277013. Epub 1997/01/01. eng.
3. Schwartz E, Hatz C, Blum J,. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 2006; 6: 342-349. PubMed PMID: 16728320. Epub 2006/05/27. eng.
4. Antinori S, Schifanella L, Corbellino M,. Leishmaniasis: new insights from an old and neglected disease. Eur J Clin Microbiol Infect Dis 2012; 31: 109-118. PubMed PMID: 21533874. Epub 2011/05/03. eng.
5. Mosleh IM, Geith E, Natsheh L, Abdul-Dayem M, Abotteen N,. Cutaneous leishmaniasis in the Jordanian side of the Jordan Valley: severe under-reporting and consequences on public health management. Trop Med Int Health 2008; 13: 855-60. PubMed PMID: 18363585. Epub 2008/03/28. eng.
6. Dujardin JC, Campino L, Canavate C, et al,. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis 2008; 14: 1013-1018. PubMed PMID: 18598618. Epub 2008/07/05. eng.
7. Maroli M, Rossi L, Baldelli R, et al,. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop Med Int Health 2008; 13: 256-264. PubMed PMID: 18304273. Epub 2008/02/29. eng.
8. Morosetti G, Bongiorno G, Beran B, et al,. Risk assessment for canine leishmaniasis spreading in the north of Italy. Geospat Health 2009; 4: 115-127. PubMed PMID: 19908194. Epub 2009/11/13. eng.
9. Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, Ferroglio E,. Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic. J Clin Microbiol 2010; 48: 131-136. PubMed PMID: 19923480. Epub 2009/11/20. eng.
10. Naucke TJ, Schmitt C,. Is leishmaniasis becoming endemic in Germany? Int J Med Microbiol 2004; 293 Suppl 37: 179-181. PubMed PMID: 15147005. Epub 2004/05/19. eng.
11. Naucke TJ, Menn B, Massberg D, Lorentz S,. Sandflies and leishmaniasis in Germany. Parasitol Res 2008; 103 Suppl 1: S65-S68. PubMed PMID: 19030887. Epub 2008/12/17. eng.
12. Ready PD,. Leishmaniasis emergence in Europe. Euro Surveill 2010; 15: 19505. PubMed PMID: 20403308. Epub 2010/04/21. eng.
13. Douba MD, Abbas O, Wali A, et al,. Chronic cutaneous leishmaniasis, a great mimicker with various clinical presentations: 12 years experience from Aleppo. J Eur Acad Dermatol Venereol 2012; 26: 1224-1229. PubMed PMID: 21958339. Epub 2011/10/01. eng.
14. Ghosn S, Dahdah MJ, Kibbi AG,. Mutilating lupoid leishmaniasis: twelve years to make the diagnosis! Dermatology 2008; 216: 187-189. PubMed PMID: 18216488. Epub 2008/01/25. eng.
15. Rowden G,. The Langerhans cell. Crit Rev Immunol 1981; 3: 95-180. PubMed PMID: 6178552. Epub 1981/12/01. eng.
16. Wolff K, Stingl G,. The Langerhans cell. J Invest Dermatol 1983; 80 Suppl: 17s-21s. PubMed PMID: 6343515. Epub 1983/06/01. eng.
17. Moll H,. Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response. Adv Exp Med Biol 1993; 329: 587-592. PubMed PMID: 8379429. Epub 1993/01/01. eng.
18. Moll H, Fuchs H, Blank C, Rollinghoff M,. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells. Eur J Immunol 1993; 23: 1595-1601. PubMed PMID: 8325337. Epub 1993/07/01. eng.
19. ', Esterre P, Dedet JP, Frenay C, Chevallier M, Grimaud JA,. Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1992; 421: 239-247. PubMed PMID: 1413489. Epub 1992/01/01. eng.
20. Moll H, Flohe S, Rollinghoff M,. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur J Immunol 1995; 25: 693-699. PubMed PMID: 7705398. Epub 1995/03/01. eng.
21. Moll H, Flohe S,. Dendritic cells induce immunity to cutaneous leishmaniasis in mice. Adv Exp Med Biol 1997; 417: 541-545. PubMed PMID: 9286417. Epub 1997/01/01. eng.
22. Aberer W, Schuler G, Stingl G, Honigsmann H, Wolff K,. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981; 76: 202-210. PubMed PMID: 6453905. Epub 1981/03/01. eng.
23. Krueger GG, Emam M,. Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin. J Invest Dermatol 1984; 82: 613-617. PubMed PMID: 6373958. Epub 1984/06/01. eng.
24. Giannini MS,. Suppression of pathogenesis in cutaneous leishmaniasis by UV irradiation. Infect Immun 1986; 51: 838-843. PubMed PMID: 3949383. Epub 1986/03/01. eng.
25. Breathnach SM, Katz SI,. Effect of X-irradiation on epidermal immune function: decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF). J Invest Dermatol 1985; 85: 553-558. PubMed PMID: 3877770. Epub 1985/12/01. eng.
26. Ashworth J, Booker J, Breathnach SM,. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin. Br J Dermatol 1988; 118: 457-469. PubMed PMID: 3288268. Epub 1988/04/01. eng.
27. Dam TN, Moller B, Hindkjaer J, Kragballe K,. The vitamin D3 analog calcipotriol suppresses the number and antigen-presenting function of Langerhans cells in normal human skin. J Investig Dermatol Symp Proc 1996; 1: 72-77. PubMed PMID: 9627697. Epub 1996/04/01. eng.
28. Meymandi S, Dabiri S, Dabiri D, Crawford RI, Kharazmi A,. A quantitative study of epidermal Langerhans cells in cutaneous leishmaniasis caused by Leishmania tropica. Int J Dermatol 2004; 43: 819-823. PubMed PMID: 15533064. Epub 2004/11/10. eng.
29. Karram S, Loya A, Hamam H, Habib RH, Khalifeh I,. Transepidermal elimination in cutaneous leishmaniasis: a multiregional study. J Cutan Pathol 2012; 39: 406-412. PubMed PMID: 22443392. Epub 2012/03/27. eng.
30. Ridley DS,. A histological classification of cutaneous leishmaniasis and its geographical expression. Trans R Soc Trop Med Hyg 1980; 74: 515-521. PubMed PMID: 7445049. Epub 1980/01/01. eng.
31. Ridley DS, Ridley MJ,. The evolution of the lesion in cutaneous leishmaniasis. J Pathol 1983; 141: 83-96.
32. Amiot M, Dastot H, Degos L, Dausset J, Bernard A, Boumsell L,. HLA class I molecules are associated with CD1a heavy chains on normal human thymus cells. Proc Natl Acad Sci USA 1988; 85: 4451-4454. PubMed PMID: 2454469. Epub 1988/06/01. eng.
33. Favali C, Tavares N, Clarencio J, Barral A, Barral-Netto M, Brodskyn C,. Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leukoc Biol 2007; 82: 1401-1406. PubMed PMID: 17890507. Epub 2007/09/25. eng.
34. Donovan MJ, Jayakumar A, McDowell MA,. Inhibition of groups 1 and 2 CD1 molecules on human dendritic cells by Leishmania species. Parasite Immunol 2007; 29: 515-524. PubMed PMID: 17883454. Epub 2007/09/22. eng.
35. McCalmont TH,. Caveat emptor. J Cutan Pathol 2012; 39: 479-480. PubMed PMID: 22515219
36. Ismail A, Khalil EA, Musa AM, et al,. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role? Med Hypotheses 2006; 66: 993-999. PubMed PMID: 16386855.
37. Kautz-Neu K, Noordegraaf M, Dinges S, et al,. Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 2011; 208: 885-891. PubMed PMID: 21536741. Epub 2011/05/04. eng.
38. Miyagawa F, Okiyama N, Villarroel V, Katz SI,. Identification of CD3(+)CD4(-)CD8(-) T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD). J Invest Dermatol 2013; 133: 2538-2545. PubMed PMID: 23648548. Epub 2013/05/08. eng.
39. Antonelli LR, Dutra WO, Oliveira RR, et al,. Disparate immunoregulatory potentials for double-negative (CD4- CD8-) alpha beta and gamma delta T cells from human patients with cutaneous leishmaniasis. Infect Immun 2006; 74: 6317-6323. PubMed PMID: 16923794. Pubmed Central PMCID: 1695524.
40. Markikou-Ouni W, Ben Achour-Chenik Y, Meddeb-Garnaoui A,. Effects of Leishmania major clones showing different levels of virulence on infectivity, differentiation and maturation of human dendritic cells. Clin Exp Immunol 2012; 169: 273-280. PubMed PMID: 22861367. Epub 2012/08/07. eng.
41. Wu CY, Kirman JR, Rotte MJ, et al,. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3: 852-858. PubMed PMID: 12172546. Epub 2002/08/13. eng.
42. Whitmire JK, Benning N, Whitton JL,. Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+ T cell responses. J Immunol 2005; 175: 5624-5628. PubMed PMID: 16237051. Epub 2005/10/21. eng.
43. Luft T, Pang KC, Thomas E, et al,. Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 1998; 161: 1947-1953. PubMed PMID: 9712065. Epub 1998/08/26. eng.
44. Ford MS, Young KJ, Zhang Z, Ohashi PS, Zhang L,. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 2002; 196: 261-267. PubMed PMID: 12119351. Epub 2002/07/18. eng.
45. Thomson CW, Lee BP, Zhang L,. Double-negative regulatory T cells: non-conventional regulators. Immunol Res 2006; 35: 163-178. PubMed PMID: 17003518. Epub 2006/09/28. eng.
46. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL,. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420: 502-507. PubMed PMID: 12466842. Epub 2002/12/06. eng.
47. Gao JF, McIntyre MS, Juvet SC, et al,. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells. Eur J Immunol 2011; 41: 2699-2708. PubMed PMID: 21660936. Epub 2011/06/11. eng.
48. Xavier MB, Silveira FT, Demachki S, Ferreira MM, do Nascimento JL,. American tegumentary leishmaniasis: a quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus. Acta Trop 2005; 95: 67-73. PubMed PMID: 15935321.
49. Isaza DM, Restrepo M, Restrepo R, Caceres-Dittmar G, Tapia FJ,. Immunocytochemical and histopathologic characterization of lesions from patients with localized cutaneous leishmaniasis caused by Leishmania panamensis. Am J Trop Med Hyg 1996; 55: 365-369. PubMed PMID: 8916790.
50. Meymandi S, Dabiri S, Shamsi-Meymandi M, Nikpour H, Kharazmi A,. Immunophenotypic pattern and cytokine profiles of dry type cutaneous leishmaniasis. Arch Iran Med 2009; 12: 371-376. PubMed PMID: 19566354.
51. Neves BM, Silvestre R, Resende M, et al,. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am J Pathol 2010; 177: 2898-2911. PubMed PMID: 21037075. Pubmed Central PMCID: 2993270.
52. Brandonisio O, Spinelli R, Pepe M,. Dendritic cells in Leishmania infection. Microbes Infect 2004; 6: 1402-1409. PubMed PMID: 15596127.
53. Diaz NL, Zerpa O, Ponce LV, Convit J, Rondon AJ, Tapia FJ,. Intermediate or chronic cutaneous leishmaniasis: leukocyte immunophenotypes and cytokine characterisation of the lesion. Exp Dermatol 2002; 11: 34-41. PubMed PMID: 11952826.
54. Geiger B, Wenzel J, Hantschke M, Haase I, Stander S, von Stebut E,. Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells. Br J Dermatol 2010; 162: 870-874. PubMed PMID: 19906074.
55. Firouzmand H, Badiee A, Khamesipour A, et al,. Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA). Acta Trop 2013; 128: 528-535. PubMed PMID: 23916506. Epub 2013/08/07. Eng.
56. Wu W, Huang L, Mendez S,. A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice. Eur J Immunol 2010; 40: 2517-2527. PubMed PMID: 20683901. Epub 2010/08/05. eng.
57. Darrah PA, Patel DT, De Luca PM, et al,. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843-850. PubMed PMID: 17558415. Epub 2007/06/15. eng.
58. Flohe SB, Bauer C, Flohe S, Moll H,. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur J Immunol 1998; 28: 3800-3811. PubMed PMID: 9842923.
59. Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H,. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol 2003; 170: 3171-3179. PubMed PMID: 12626575.
60. Stacey KJ, Blackwell JM,. Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. Infect Immun 1999; 67: 3719-3726. PubMed PMID: 10417129. Pubmed Central PMCID: 96645.
61. Rudd CE,. The reverse stop-signal model for CTLA4 function. Nat Rev Immunol 2008; 8: 153-160. PubMed PMID: 18219311. Epub 2008/01/26. eng.
62. Cavassani KA, Campanelli AP, Moreira AP, et al,. Systemic and local characterization of regulatory T cells in a chronic fungal infection in humans. J Immunol 2006 Nov 1; 177: 5811-5818. PubMed PMID: 17056505.
63. McGaha T, Murphy JW,. CTLA-4 down-regulates the protective anticryptococcal cell-mediated immune response. Infect Immun 2000; 68: 4624-4630. PubMed PMID: 10899865. Epub 2000/07/19. eng.
64. Pedicord VA, Montalvo W, Leiner IM, Allison JP,. Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance. Proc Natl Acad Sci USA 2011; 108: 266-271. PubMed PMID: 21173239. Epub 2010/12/22. eng.
65. Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G,. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors. Cancer Res 2013; 73: 3591-3603. PubMed PMID: 23633484. Epub 2013/05/02. eng.